-Healthcare Supply Chain Forum：Reboot and Rebuild- Taiwan-Japan Innovation & Collaboration in Therapeutics
2021-11-18 15:36:00
Previous Next Return to the news

 

-Healthcare Supply Chain Forum：Reboot and Rebuild-
Taiwan-Japan Innovation & Collaboration in Therapeutics

Japan in pharmaceuticals leaps with innovations and technologies. Most recently the case has been cell therapies and specialised medicines (orphan drugs). The forum, co-organised by Japan Pharmaceutical Licensing Association (JPLA), invites companies in the spotlight- SOCIUM and United Immunity- to articulate their clinical research and progresses made in AI-driven drug discovery and immunotherapy powered by nanoparticulate delivery technology, respectively.

13:00 (GMT+8)；14:00 (GMT+9), Wednesday 1 December

Organiser:
Research Center for Biotechnology and Medicine Policy, Taiwan
Development Center for Biotechnology, Taiwan
Japan Pharmaceutical Licensing Association (JPLA)

Agenda

Time (GMT+8)
Topic
Speaker
Video
13:00-13:05
Opening Remark
Chung-Hsiun Wu, President, Development Center for Biotechnology (DCB)
Time (GMT+8)
Topic
Speaker
Video
13:05-13:10
Opening Remark
Kazuko Yokota, Represevtive, Japan Pharmaceutical Licensing Association (JPLA)
Time (GMT+8)
Topic
Speaker
Video
13:10-13:30
Keynote Speech The Power of Science Innovation in Japan ~ what we do well and where we need help ~
Toru Jay Seo, CEO, Lucidaim
Company Session
Time (GMT+8)
Topic
Speaker
Video
13:30-13:40
A future trend of AI-driven drug discovery and development.
Hiroshi Kawai, CEO, SOCIUM
Time (GMT+8)
Topic
Speaker
Video
13:40-13:50
Transforming Cancer Immunotherapy by Utilizing a Novel Tumor-Associated Macrophage-Selective Nanoparticulate Delivery System
Harada Naozumi, CEO, United Immunity
Time (GMT+8)
Topic
Speaker
Video
13:50-14:00
Innovations for health. TTS for improved patients’outcome
Stefan Arnold, Director Business Development Asia, LTS Lohmann Therapie-Systeme AG
Time (GMT+8)
Topic
Speaker
Video
14:00-14:10
Common challenges for business development at SMEs, and lean BD scheme
Kazushi Kamitani, Managing Director, Japan Pharma Research Office
Time (GMT+8)
Topic
Speaker
Video
14:10-14:20
Novel Medications For Better Elderly Care - Patch and Oral Film.
Milky Kao, Vice President BD, TAHO Pharmaceuticals Ltd.
Time (GMT+8)
Topic
Speaker
Video
14:20-14:30
AD17002 in Mucosal Immunotherapy
Bryon Chen, Chairman, Advagene Biopharma Co., Ltd.
Time (GMT+8)
Topic
Speaker
Video
14:30-14:40
AI-assisted medicine, genomics information and clinical data analysis solutions.
Ethan Tu, Founer, Taiwan AI labs

 

Previous Healthcare Supply Chain Forum 2021 (Online)
Next -Healthcare Supply Chain Forum：Reboot and Rebuild- Taiwan-Poland Healthcare Industry, Eyeing on Eurasian Market Expansion and Collaboration
Return to the news
© Institute for Biotechnology and Medicine Industry & Research Center for Biotechnology and Medicine Policy
Contact Us
Follow Us
Loading...